SPARCL1 and breast cancer: Similarly, secreted protein acidic and rich in cysteine-like protein 1 (SPARCL1) was another ECM-glycoprotein whose reduced expression was reported in human breast cancer tissues, and NVA-AA NP treatment caused an increase in the SPARCL1 expression (74).